264 related articles for article (PubMed ID: 23667258)
1. Structure-based discovery of antagonists of nuclear receptor LRH-1.
Benod C; Carlsson J; Uthayaruban R; Hwang P; Irwin JJ; Doak AK; Shoichet BK; Sablin EP; Fletterick RJ
J Biol Chem; 2013 Jul; 288(27):19830-44. PubMed ID: 23667258
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferation activity of a small molecule repressor of liver receptor homolog 1.
Corzo CA; Mari Y; Chang MR; Khan T; Kuruvilla D; Nuhant P; Kumar N; West GM; Duckett DR; Roush WR; Griffin PR
Mol Pharmacol; 2015 Feb; 87(2):296-304. PubMed ID: 25473120
[TBL] [Abstract][Full Text] [Related]
3. Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer.
Nadolny C; Dong X
Cancer Biol Ther; 2015; 16(7):997-1004. PubMed ID: 25951367
[TBL] [Abstract][Full Text] [Related]
4. The liver receptor homolog-1 (LRH-1) is expressed in human islets and protects {beta}-cells against stress-induced apoptosis.
Baquié M; St-Onge L; Kerr-Conte J; Cobo-Vuilleumier N; Lorenzo PI; Jimenez Moreno CM; Cederroth CR; Nef S; Borot S; Bosco D; Wang H; Marchetti P; Pattou F; Wollheim CB; Gauthier BR
Hum Mol Genet; 2011 Jul; 20(14):2823-33. PubMed ID: 21536586
[TBL] [Abstract][Full Text] [Related]
5. Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner.
Lee YK; Moore DD
J Biol Chem; 2002 Jan; 277(4):2463-7. PubMed ID: 11668176
[TBL] [Abstract][Full Text] [Related]
6. Repression of the promoter activity mediated by liver receptor homolog-1 through interaction with ku proteins.
Ohno M; Komakine J; Suzuki E; Nishizuka M; Osada S; Imagawa M
Biol Pharm Bull; 2010; 33(5):784-91. PubMed ID: 20460755
[TBL] [Abstract][Full Text] [Related]
7. The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation.
Chand AL; Wijayakumara DD; Knower KC; Herridge KA; Howard TL; Lazarus KA; Clyne CD
PLoS One; 2012; 7(2):e31593. PubMed ID: 22359603
[TBL] [Abstract][Full Text] [Related]
8. Interleukin enhancer-binding factor 3 functions as a liver receptor homologue-1 co-activator in synergy with the nuclear receptor co-activators PRMT1 and PGC-1α.
Ohno M; Komakine J; Suzuki E; Nishizuka M; Osada S; Imagawa M
Biochem J; 2011 Aug; 437(3):531-40. PubMed ID: 21554248
[TBL] [Abstract][Full Text] [Related]
9. Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation.
Benod C; Vinogradova MV; Jouravel N; Kim GE; Fletterick RJ; Sablin EP
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):16927-31. PubMed ID: 21949357
[TBL] [Abstract][Full Text] [Related]
10. Structure of Liver Receptor Homolog-1 (NR5A2) with PIP3 hormone bound in the ligand binding pocket.
Sablin EP; Blind RD; Uthayaruban R; Chiu HJ; Deacon AM; Das D; Ingraham HA; Fletterick RJ
J Struct Biol; 2015 Dec; 192(3):342-348. PubMed ID: 26416531
[TBL] [Abstract][Full Text] [Related]
11. The Orphan Nuclear Receptors Steroidogenic Factor-1 and Liver Receptor Homolog-1: Structure, Regulation, and Essential Roles in Mammalian Reproduction.
Meinsohn MC; Smith OE; Bertolin K; Murphy BD
Physiol Rev; 2019 Apr; 99(2):1249-1279. PubMed ID: 30810078
[TBL] [Abstract][Full Text] [Related]
12. Unexpected Allosteric Network Contributes to LRH-1 Co-regulator Selectivity.
Musille PM; Kossmann BR; Kohn JA; Ivanov I; Ortlund EA
J Biol Chem; 2016 Jan; 291(3):1411-26. PubMed ID: 26553876
[TBL] [Abstract][Full Text] [Related]
13. POD-1/TCF21 Reduces SHP Expression, Affecting LRH-1 Regulation and Cell Cycle Balance in Adrenocortical and Hepatocarcinoma Tumor Cells.
França MM; Ferraz-de-Souza B; Lerario AM; Fragoso MC; Lotfi CF
Biomed Res Int; 2015; 2015():841784. PubMed ID: 26421305
[TBL] [Abstract][Full Text] [Related]
14. New High-Throughput Screen Discovers Novel Ligands of Full-Length Nuclear Receptor LRH-1.
Malabanan MM; Chapagain P; Haratipour Z; Choi WJ; Orun AR; Blind RD
ACS Chem Biol; 2023 May; 18(5):1101-1114. PubMed ID: 37074920
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a new class of liver receptor homolog-1 (LRH-1) antagonists: virtual screening, synthesis and biological evaluation.
Rey J; Hu H; Kyle F; Lai CF; Buluwela L; Coombes RC; Ortlund EA; Ali S; Snyder JP; Barrett AG
ChemMedChem; 2012 Nov; 7(11):1909-14. PubMed ID: 22961990
[TBL] [Abstract][Full Text] [Related]
16. Structural and biochemical basis for selective repression of the orphan nuclear receptor liver receptor homolog 1 by small heterodimer partner.
Li Y; Choi M; Suino K; Kovach A; Daugherty J; Kliewer SA; Xu HE
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9505-10. PubMed ID: 15976031
[TBL] [Abstract][Full Text] [Related]
17. Synergistic regulation of the mouse orphan nuclear receptor SHP gene promoter by CLOCK-BMAL1 and LRH-1.
Oiwa A; Kakizawa T; Miyamoto T; Yamashita K; Jiang W; Takeda T; Suzuki S; Hashizume K
Biochem Biophys Res Commun; 2007 Feb; 353(4):895-901. PubMed ID: 17204240
[TBL] [Abstract][Full Text] [Related]
18. Nuclear-mitochondrial crosstalk: On the role of the nuclear receptor liver receptor homolog-1 (NR5A2) in the regulation of mitochondrial metabolism, cell survival, and cancer.
Michalek S; Brunner T
IUBMB Life; 2021 Mar; 73(3):592-610. PubMed ID: 32931651
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of Liver Receptor Homolog-1 modulators.
Lazarus KA; Wijayakumara D; Chand AL; Simpson ER; Clyne CD
J Steroid Biochem Mol Biol; 2012 Jul; 130(3-5):138-46. PubMed ID: 22266285
[TBL] [Abstract][Full Text] [Related]
20. Liver receptor homolog-1 (NR5a2) regulates CD95/Fas ligand transcription and associated T-cell effector functions.
Schwaderer J; Gaiser AK; Phan TS; Delgado ME; Brunner T
Cell Death Dis; 2017 Apr; 8(4):e2745. PubMed ID: 28406481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
